Physician profile
Ryan Qasawa
NPI 1134650831
$4,379.98
in general payments reported to CMS, 2019-2025
21 companies · $2,840 in 2025
The $2,840 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $58.80 · 2021: $63.63 · 2022: $547 · 2023: $167 · 2024: $704 · 2025: $2,840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,084 · Travel and Lodging: $1,626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,084.24 |
| Travel and Lodging | $1,626.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,419.79 | 2023-2025 | |
| Integra Lifesciences Corporation | $356.95 | 2022 | |
| Mentor Worldwide LLC | $295.21 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Polynovo North America LLC | $240.74 | 2024 | Novosorb Btm |
| Allergan, INC. | $206.22 | 2020-2022 | |
| Depuy Synthes Sales INC. | $149.16 | 2024-2025 | Trumatch, Na |
| Heron Therapeutics, INC. | $122.93 | 2025 | Zynrelef |
| Mimedx Group, INC. | $84.20 | 2025 | |
| Motiva USA, LLC | $75.00 | 2025 | |
| Stryker Corporation | $74.41 | 2023 | Hydroset, Na |
| Medtronic, INC. | $62.17 | 2022-2025 | V-Loc 180 |
| Smith+Nephew, INC. | $61.49 | 2025 | Renasys Touch, Renasys Go V2 Home |
| Baxter Healthcare | $44.75 | 2025 | Artiss |
| Davol INC. | $37.17 | 2022 | |
| Organogenesis INC. | $30.32 | 2025 | Puraply Wound Matrix |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgenex LLC | $28.04 | 2025 | Ardeograft, Surgraft, Surmatrix |
| Hydrofera LLC | $24.61 | 2023 | Hydrofera Blue Ready - Border |
| Access Pro Medical, LLC | $20.54 | 2025 | Matriderm |
| Convatec INC. | $20.24 | 2022 | |
| Aesculap, INC. | $13.57 | 2024 | Aesculap |
| Innocoll Pharmaceuticals Limited | $12.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Qasawa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.